Erratum: Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells (Leukemia (April 2011) DOI:10.1038/leu.2011.62);Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells

Leukemia

Volumn 25, Issue 8, 2011, Pages 1286-1296

  Dar, A ^a   Schajnovitz, A ^a   Lapid, K ^a   Kalinkovich, A ^a   Itkin, T ^a   Ludin, A ^b   Kao, W M ^b   Battista, M ^b   Tesio, M ^a   Kollet, O ^a   Cohen, N N ^a   Margalit, R ^a   Buss, E C ^a   Baleux, F ^c   Oishi, S ^d   Fujii, N ^d   Larochelle, A ^e   Dunbar, C E ^e   Broxmeyer, H E ^f   Frenette, P S ^b   Lapidot, T ^a   more..

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c INSTITUT PASTEUR   (France)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AMD3100; catecholamines; hematopoietic progenitor cells; rapid mobilization; SDF 1 CXCR4; uPA

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE DERIVATIVE; CHEMOKINE RECEPTOR CXCR4; NEUTRALIZING ANTIBODY; NORADRENALIN; PLERIXAFOR; REACTIVE OXYGEN METABOLITE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOTINYLATION; CYTOKINE RELEASE; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INHIBITION; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INJECTION; LEUKOCYTE; MOUSE; NONHUMAN; OSTEOBLAST; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEADY STATE; STEM CELL MOBILIZATION;

EID: 80051796965     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.132     Document Type: Erratum

References (66)

1. Spiegel A, Kalinkovich A, Shivtiel S, Kollet O, Lapidot T. Stem cell regulation via dynamic interactions of the nervous and immune systems with the microenvironment. Cell Stem Cell 2008;3:484-492.
2. Lapidot T, Kollet O. The Brain-Bone-Blood Triad: Traffic Lights for Stem-Cell Homing and Mobilization. Hematology Am Soc Hematol Educ Program 2010;1-6.
3. Wright DE, Wagers AJ, Gulati AP, Johnson FL, Weissman IL. Physiological migration of hematopoietic stem and progenitor cells. Science 2001;294:1933-1936. (Pubitemid 33101591)
4. Kollet O, Dar A, Lapidot T. The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization. Annu Rev Immunol 2007;25:51-69. (Pubitemid 46697902)
5. Lapid K, Vagima Y, Kollet O, Lapidot T. Egress and mobilization of hematopoietic progenitor cells. StemBook, Harvard Stem Cell Institute 2009;1.39.1.
6. Lapidot T, Petit I. Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002;30:973-981. (Pubitemid 35286613)
7. Petit I, Szyper-Kravitz M, Nagler A, Lahav M, Peled A, Habler L et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002;3:687-694. (Pubitemid 34752479)
8. Papayannopoulou T, Scadden DT. Stem-cell ecology and stem cells in motion. Blood 2008;111:3923-3930.
9. Dar A, Kollet O, Lapidot T. Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice. Exp Hematol 2006;34:967-975. (Pubitemid 44080383)
10. Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, Sandbank J et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000;106:1331-1339.
11. Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 2005;6:1038-1046. (Pubitemid 41486189)
12. Sugiyama T, Kohara H, Noda M, Nagasawa T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 2006;25:977-988. (Pubitemid 44894948)
13. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001;97:3354-3360.
14. Shen H, Cheng T, Olszak I, Garcia-Zepeda E, Lu Z, Herrmann S et al. CXCR-4 desensitization is associated with tissue localization of hemopoietic progenitor cells. J Immunol 2001;166:5027-5033. (Pubitemid 32280715)
15. Frenette PS, Weiss L. Sulfated glycans induce rapid hematopoietic progenitor cell mobilization: evidence for selectin-dependent and independent mechanisms. Blood 2000;96:2460-2468.
16. Sweeney EA, Lortat-Jacob H, Priestley GV, Nakamoto B, Papayannopoulou T. Sulfated polysaccharides increase plasma levels of SDF-1 in monkeys and mice: involvement in mobilization of stem/progenitor cells. Blood 2002;99:44-51.
17. Tchernychev B, Ren Y, Sachdev P, Janz JM, Haggis L, O'Shea A et al. Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells. Proc Natl Acad Sci USA 2010;107:22255-22259.
18. Mendez-Ferrer S, Lucas D, Battista M, Frenette PS. Haematopoietic stem cell release is regulated by circadian oscillations. Nature 2008;452:442-447. (Pubitemid 351450836)
19. Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 2006;124:407-421. (Pubitemid 43121987)
20. Spiegel A, Shivtiel S, Kalinkovich A, Ludin A, Netzer N, Goichberg P et al. Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat Immunol 2007;8:1123-1131. (Pubitemid 47423760)
21. Selleri C, Montuori N, Ricci P, Visconte V, Carriero MV, Sidenius N et al. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood 2005;105:2198-2205. (Pubitemid 40731813)
22. Tjwa M, Janssens S, Carmeliet P. Plasmin therapy enhances mobilization of HPCs after G-CSF. Blood 2008;112:4048-4050.
23. Tesio M, Golan K, Corso S, Giordano S, Schajnovitz A, Vagima Y et al. Enhanced c-Met activity promotes G-CSF induced mobilization of hematopoietic progenitor cells via ROS signaling. Blood 2011;117:419-428.
24. Abraham M, Beider K, Wald H, Weiss ID, Zipori D, Galun E et al. The CXCR4 antagonist 4F-benzoyl-TN14003 stimulates the recovery of the bone marrow after transplantation. Leukemia 2009;23:1378-1388.
25. Hatse S, Princen K, Bridger G, De Clercq E, Schols D. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett 2002;527:255-262. (Pubitemid 35253875)
26. Devine SM, Vij R, Rettig M, Todt L, McGlauchlen K, Fisher N et al. Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction. Blood 2008;112:990-998.
27. Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med 2005;201:1307-1318. (Pubitemid 40629073)
28. Larochelle A, Krouse A, Metzger M, Orlic D, Donahue RE, Fricker S et al. AMD3100 mobilizes hematopoietic stem cells with longterm repopulating capacity in nonhuman primates. Blood 2006;107:3772-3778.
29. Liles WC, Broxmeyer HE, Rodger E, Wood B, Hubel K, Cooper S et al. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood 2003;102:2728-2730. (Pubitemid 37248839)
30. Hess DA, Bonde J, Craft TP, Wirthlin L, Hohm S, Lahey R et al. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor. Biol Blood Marrow Transplant 2007;13:398-411. (Pubitemid 46421895)
31. Gazitt Y, Freytes CO, Akay C, Badel K, Calandra G. Improved mobilization of peripheral blood CD34+ cells and dendritic cells by AMD3100 plus granulocyte-colony-stimulating factor in non-Hodgkin's lymphoma patients. Stem Cells Dev 2007;16:657-666. (Pubitemid 47378738)
32. Cashen A, Lopez S, Gao F, Calandra G, MacFarland R, Badel K et al. A phase II study of plerixafor (AMD3100) plus G-CSF for autologous hematopoietic progenitor cell mobilization in patients with Hodgkin lymphoma. Biol Blood Marrow Transplant 2008;14:1253-1261.
33. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W et al. SP600125, an anthrapyrazolone inhibitor of Jun. N-terminal kinase. Proc Natl Acad Sci USA 2001;98:13681-13686. (Pubitemid 33115958)
34. Reca R, Cramer D, Yan J, Laughlin MJ, Janowska-Wieczorek A, Ratajczak J et al. A novel role of complement in mobilization: immunodeficient mice are poor granulocyte-colony stimulating factor mobilizers because they lack complement-activating immunoglobulins. Stem Cells 2007;25:3093-3100. (Pubitemid 350294435)
35. Amara A, Lorthioir O, Valenzuela A, Magerus A, Thelen M, Montes M et al. Stromal cell-derived factor-1alpha associates with heparan sulfates through the first beta-strand of the chemokine. J Biol Chem 1999;274:23916-23925.
36. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-638. (Pubitemid 26268957)
37. Lavi E, Strizki JM, Ulrich AM, Zhang W, Fu L, Wang Q et al. CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol 1997;151:1035-1042. (Pubitemid 27424313)
38. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393:595-599. (Pubitemid 28319251)
39. Serrati S, Margheri F, Fibbi G, Di Cara G, Minafra L, Pucci-Minafra I et al. Endothelial cells and normal breast epithelial cells enhance invasion of breast carcinoma cells by CXCR-4-dependent upregulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. J Pathol 2008;214:545-554. (Pubitemid 351492460)
40. Jin DK, Shido K, Kopp HG, Petit I, Shmelkov SV, Young LM et al. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006;12:557-567.
41. Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y et al. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 2006;12:657-664. (Pubitemid 43865234)
42. Massberg S, Konrad I, Schurzinger K, Lorenz M, Schneider S, Zohlnhoefer D et al. Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006;203:1221-1233. (Pubitemid 43736592)
43. Petit I, Jin D, Rafii S. The SDF-1-CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesis. Trends Immunol 2007;28:299-307. (Pubitemid 46963141)
44. Wang Y, Cui L, Gonsiorek W, Min SH, Anilkumar G, Rosenblum S et al. CCR2 and CXCR4 regulate peripheral blood monocyte pharmacodynamics and link to efficacy in experimental autoimmune encephalomyelitis. J Inflamm (Lond) 2009;6:32.
45. Tepper OM, Carr J, Allen Jr RJ, Chang CC, Lin CD, Tanaka R et al. Decreased circulating progenitor cell number and failed mechanisms of stromal cell-derived factor-1alpha mediated bone marrow mobilization impair diabetic tissue repair. Diabetes 2010;59:1974-1983.
46. Bonig H, Chudziak D, Priestley G, Papayannopoulou T. Insights into the biology of mobilized hematopoietic stem/progenitor cells through innovative treatment schedules of the CXCR4 antagonist AMD3100. Exp Hematol 2009;37:402-415e1.
47. Allende ML, Tuymetova G, Lee BG, Bonifacino E, Wu YP, Proia RL. S1P1 receptor directs the release of immature B cells from bone marrow into blood. J Exp Med 2010;207:1113-1124.
48. Downey N, Thien M, Juares J, Bradstock K, Bendall L. Sphingosine-1- phosphate mediates the egress of hematopoietic stem cells from the bone marrow into the peripheral blood. Exp Hematol ISEH Ann Meet 2010;38:Abstract 122.
49. Golan K, Vagima Y, Ludin A, Itkin T, Kalinkovich A, Cohen-Gur S et al. The lipid chemokine S1P regulates hematopoietic progenitor cell egress and mobilization via its major receptor S1P1 and by SDF-1 inhibition, in a p38/Akt/mTOR dependent manner. ASH Ann Meeting Abstr 2010;116:Abstract 553.
50. Ratajczak MZ, Lee H, Wysoczynski M, Wan W, Marlicz W, Laughlin MJ et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 2010;24:976-985.
51. Ratajczak MZ, Kim CH, Wojakowski W, Janowska-Wieczorek A, Kucia M, Ratajczak J. Innate immunity as orchestrator of stem cell mobilization. Leukemia 2010;24:1667-1675.
52. Ross J. FGFR1 Is Required for and Elucidates Multiple Mechanisms of HSC Mobilization. ASH Ann Meet Abstr 2009;114:Abstract 2532.
53. Donzella GA, Schols D, Lin SW, Este JA, Nagashima KA, Maddon PJ et al. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor. Nat Med 1998;4:72-77. (Pubitemid 28133082)
54. Schols D, Struyf S, Van Damme J, Este JA, Henson G, De Clercq E. Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997;186:1383-1388. (Pubitemid 27469034)
55. Hendrix CW, Collier AC, Lederman MM, Schols D, Pollard RB, Brown S et al. Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection. J Acquir Immune Defic Syndr 2004;37:1253-1262. (Pubitemid 39281506)
56. Zabel BA, Wang Y, Lewen S, Berahovich RD, Penfold ME, Zhang P et al. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 2009;183:3204-3211.
57. Yamazaki K, Allen TD. Ultrastructural morphometric study of efferent nerve terminals on murine bone marrow stromal cells, and the recognition of a novel anatomical unit: the 'neuro-reticular complex'. Am J Anat 1990;187:261-276. (Pubitemid 20096901)
58. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997;185:111-120. (Pubitemid 27039446)
59. Semerad CL, Christopher MJ, Liu F, Short B, Simmons PJ, Winkler I et al. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow. Blood 2005;106:3020-3027. (Pubitemid 41565894)
60. Christopher MJ, Liu F, Hilton MJ, Long F, Link DC. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine-induced mobilization. Blood 2009;114:1331-1339.
61. Lee HM, Wysoczynski M, Liu R, Shin DM, Kucia M, Botto M et al. Mobilization studies in complement-deficient mice reveal that optimal AMD3100 mobilization of hematopoietic stem cells depends on complement cascade activation by AMD3100-stimulated granulocytes. Leukemia 2009;24:573-582.
62. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002;109:625-637. (Pubitemid 34628725)
63. Pelus LM, Bian H, King AG, Fukuda S. Neutrophil-derived MMP-9 mediates synergistic mobilization of hematopoietic stem and progenitor cells by the combination of G-CSF and the chemokines GRObeta/CXCL2 and GRObetaT/CXCL2delta4. Blood 2004;103:110-119. (Pubitemid 38029925)
64. Jujo K, Hamada H, Iwakura A, Thorne T, Sekiguchi H, Clarke T et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc Natl Acad Sci USA 2010;107:11008-11013.
65. Heissig B, Lund LR, Akiyama H, Ohki M, Morita Y, Romer J et al. The plasminogen fibrinolytic pathway is required for hematopoietic regeneration. Cell Stem Cell 2007;1:658-670. (Pubitemid 350215332)
66. Binder BR, Mihaly J, Prager GW. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view. Thromb Haemost 2007;97:336-342. (Pubitemid 46437793)